LivaNova PLC Increase (Decrease) in Accounts Receivable
LivaNova PLC (LIVN) reported Increase (Decrease) in Accounts Receivable of $17.15 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-05
- LivaNova PLC increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $2.48M, a 74.59% decline year-over-year.
- LivaNova PLC increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $14.67M, a 276.51% increase year-over-year.
- LivaNova PLC increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $4.88M, a 23.41% decline year-over-year.
- LivaNova PLC increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was -$7.84M.
- LivaNova PLC increase (decrease) in accounts receivable for fiscal 2025 was $10.71M.
- LivaNova PLC increase (decrease) in accounts receivable for fiscal 2024 was -$11.06M, a 138.32% decline from fiscal 2023.
- LivaNova PLC increase (decrease) in accounts receivable for fiscal 2023 was $28.86M, a 500.08% increase from fiscal 2022.
- LivaNova PLC increase (decrease) in accounts receivable for fiscal 2022 was $4.81M, a 69.45% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 8 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month | Increase (Decrease) in Accounts Receivable 20 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $17.15M 10-Q · filed 2026-08-05 | $22.03M derived: sum of 3 quarters · filed 2026-08-05 | $14.19M derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2026-03-31 | $14.67M 10-Q · filed 2026-05-06 | $19.54M derived: sum of 2 quarters · filed 2026-05-06 | $11.70M derived: sum of 3 quarters · filed 2026-05-06 | $21.48M derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-12-31 | $4.88M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$2.97M derived: sum of 2 quarters · filed 2026-02-25 | $6.81M derived: sum of 3 quarters · filed 2026-08-05 | $10.71M 10-K · filed 2026-02-25 | ||
| 2025-09-30 | -$7.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $1.93M derived: sum of 2 quarters · filed 2026-08-05 | $5.83M 10-Q · filed 2025-11-05 | $12.20M derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-06-30 | $9.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $13.67M 10-Q · filed 2026-08-05 | $20.04M derived: sum of 3 quarters · filed 2026-08-05 | $11.01M derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-03-31 | $3.90M 10-Q · filed 2026-05-06 | $10.26M derived: sum of 2 quarters · filed 2026-05-06 | $1.23M derived: sum of 3 quarters · filed 2026-05-06 | -$5.17M derived: sum of 4 quarters · filed 2026-05-06 | ||
| 2024-12-31 | $6.37M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$2.66M derived: sum of 2 quarters · filed 2026-02-25 | -$9.07M derived: sum of 3 quarters · filed 2026-02-25 | -$11.06M 10-K · filed 2026-02-25 | ||
| 2024-09-30 | -$9.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$15.43M derived: sum of 2 quarters · filed 2025-11-05 | -$17.43M 10-Q · filed 2025-11-05 | $3.20M derived: sum of 4 quarters · filed 2026-02-25 | ||
| 2024-06-30 | -$6.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$8.40M 10-Q · filed 2025-08-06 | $12.23M derived: sum of 3 quarters · filed 2026-02-25 | $19.76M derived: sum of 4 quarters · filed 2026-02-25 | ||
| 2024-03-31 | -$1.99M 10-Q · filed 2025-05-07 | $18.63M derived: sum of 2 quarters · filed 2026-02-25 | $26.17M derived: sum of 3 quarters · filed 2026-02-25 | $34.43M derived: sum of 4 quarters · filed 2026-02-25 | ||
| 2023-12-31 | $20.63M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $28.16M derived: sum of 2 quarters · filed 2026-02-25 | $36.42M derived: sum of 3 quarters · filed 2026-02-25 | $28.86M 10-K · filed 2026-02-25 | ||
| 2023-09-30 | $7.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $15.80M derived: sum of 2 quarters · filed 2024-10-31 | $8.24M 10-Q · filed 2024-10-31 | $11.38M derived: sum of 4 quarters · filed 2025-02-25 | ||
| 2023-06-30 | $8.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $707.00K 10-Q · filed 2024-08-01 | $3.85M derived: sum of 3 quarters · filed 2025-02-25 | $4.64M derived: sum of 4 quarters · filed 2025-02-25 | ||
| 2023-03-31 | -$7.56M 10-Q · filed 2024-05-03 | -$4.41M derived: sum of 2 quarters · filed 2025-02-25 | -$3.62M derived: sum of 3 quarters · filed 2025-02-25 | -$1.25M derived: sum of 4 quarters · filed 2025-02-25 | ||
| 2022-12-31 | $3.15M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $3.94M derived: sum of 2 quarters · filed 2025-02-25 | $6.30M derived: sum of 3 quarters · filed 2025-02-25 | $4.81M 10-K · filed 2025-02-25 | ||
| 2022-09-30 | $790.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $3.16M derived: sum of 2 quarters · filed 2023-11-01 | $1.67M 10-Q · filed 2023-11-01 | $9.56M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2022-06-30 | $2.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-26 | $875.00K 10-Q · filed 2023-07-26 | $8.77M derived: sum of 3 quarters · filed 2024-02-29 | $11.96M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2022-03-31 | -$1.49M 10-Q · filed 2023-05-03 | $6.40M derived: sum of 2 quarters · filed 2024-02-29 | $9.59M derived: sum of 3 quarters · filed 2024-02-29 | $10.88M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2021-12-31 | $7.89M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $11.08M derived: sum of 2 quarters · filed 2024-02-29 | $12.37M derived: sum of 3 quarters · filed 2024-02-29 | $15.74M 10-K · filed 2024-02-29 | ||
| 2021-09-30 | $3.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $4.48M derived: sum of 2 quarters · filed 2022-11-02 | $7.85M 10-Q · filed 2022-11-02 | $14.46M derived: sum of 4 quarters · filed 2023-02-27 | ||
| 2021-06-30 | $1.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $4.66M 10-Q · filed 2022-08-03 | $11.27M derived: sum of 3 quarters · filed 2023-02-27 | $12.12M derived: sum of 4 quarters · filed 2023-02-27 | ||
| 2021-03-31 | $3.37M 10-Q · filed 2022-05-04 | $9.98M derived: sum of 2 quarters · filed 2023-02-27 | $10.83M derived: sum of 3 quarters · filed 2023-02-27 | -$31.09M derived: sum of 4 quarters · filed 2023-02-27 | ||
| 2020-12-31 | $6.61M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $7.46M derived: sum of 2 quarters · filed 2023-02-27 | -$34.46M derived: sum of 3 quarters · filed 2023-02-27 | -$58.80M 10-K · filed 2023-02-27 | ||
| 2020-09-30 | $855.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | -$41.06M derived: sum of 2 quarters · filed 2021-11-03 | -$65.40M 10-Q · filed 2021-11-03 | -$54.65M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-06-30 | -$41.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28 | -$66.26M 10-Q · filed 2021-07-28 | -$55.50M derived: sum of 3 quarters · filed 2022-03-01 | -$61.21M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-03-31 | -$24.34M 10-Q · filed 2021-04-28 | -$13.58M derived: sum of 2 quarters · filed 2022-03-01 | -$19.29M derived: sum of 3 quarters · filed 2022-03-01 | -$11.95M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2019-12-31 | $10.75M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $5.04M derived: sum of 2 quarters · filed 2022-03-01 | $12.38M derived: sum of 3 quarters · filed 2022-03-01 | $5.32M 10-K · filed 2022-03-01 | ||
| 2019-09-30 | -$5.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $1.63M derived: sum of 2 quarters · filed 2020-10-29 | -$5.43M 10-Q · filed 2020-10-29 | $3.89M derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2019-06-30 | $7.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | $277.00K 10-Q · filed 2020-07-29 | $9.60M derived: sum of 3 quarters · filed 2021-03-01 | $895.00K derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2019-03-31 | -$7.06M 10-Q · filed 2020-04-30 | $2.26M derived: sum of 2 quarters · filed 2021-03-01 | -$6.45M derived: sum of 3 quarters · filed 2021-03-01 | -$19.14M derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2018-12-31 | $9.32M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $618.00K derived: sum of 2 quarters · filed 2021-03-01 | -$12.07M derived: sum of 3 quarters · filed 2021-03-01 | -$21.18M 10-K · filed 2021-03-01 | ||
| 2018-09-30 | -$8.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | -$21.40M derived: sum of 2 quarters · filed 2019-10-30 | -$30.51M 10-Q · filed 2019-10-30 | -$679.00K derived: sum of 4 quarters · filed 2020-03-02 | ||
| 2018-06-30 | -$12.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | -$21.80M 10-Q · filed 2019-07-31 | $8.03M derived: sum of 3 quarters · filed 2020-03-02 | $11.22M derived: sum of 4 quarters · filed 2020-03-02 | ||
| 2018-03-31 | -$9.11M 10-Q · filed 2019-05-01 | $20.72M derived: sum of 2 quarters · filed 2020-03-02 | $23.91M derived: sum of 3 quarters · filed 2020-03-02 | $46.40M derived: sum of 4 quarters · filed 2020-03-02 | ||
| 2017-12-31 | $29.83M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $33.02M derived: sum of 2 quarters · filed 2020-03-02 | $55.51M derived: sum of 3 quarters · filed 2020-03-02 | $48.93M 10-K · filed 2020-03-02 | ||
| 2017-09-30 | $3.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $25.68M derived: sum of 2 quarters · filed 2018-11-01 | $19.11M 10-Q · filed 2018-11-01 | $24.52M derived: sum of 4 quarters · filed 2019-03-18 | ||
| 2017-06-30 | $22.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $15.91M 10-Q · filed 2018-08-02 | $21.32M derived: sum of 3 quarters · filed 2019-03-18 | $5.19M derived: sum of 4 quarters · filed 2019-03-18 | ||
| 2017-03-31 | -$6.57M 10-Q · filed 2018-05-03 | -$1.17M derived: sum of 2 quarters · filed 2019-03-18 | -$17.30M derived: sum of 3 quarters · filed 2019-03-18 | $1.43M derived: sum of 4 quarters · filed 2019-03-18 | ||
| 2016-12-31 | $5.41M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | -$10.73M derived: sum of 2 quarters · filed 2019-03-18 | $8.01M derived: sum of 3 quarters · filed 2019-03-18 | $16.45M 10-K · filed 2019-03-18 | ||
| 2016-09-30 | -$16.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $2.60M derived: sum of 2 quarters · filed 2017-11-02 | $11.04M 10-Q · filed 2017-11-02 | |||
| 2016-06-30 | $18.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $27.17M 10-Q · filed 2017-08-09 | ||||
| 2016-03-31 | $8.44M 10-Q · filed 2017-05-03 | |||||
| 2015-12-31 | $15.85M 10-K · filed 2017-03-01 | $15.85M 10-K · filed 2018-02-28 | ||||
| 2015-10-18 | -$9.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | -$5.19M 10-Q · filed 2015-12-08 | -$1.43M 10-Q · filed 2016-11-02 | |||
| 2015-07-24 | $4.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $8.30M 10-Q · filed 2016-08-05 | ||||
| 2015-04-24 | $3.75M 10-Q · filed 2016-05-09 | $2.65M 10-K · filed 2018-02-28 | ||||
| 2014-10-24 | -$1.30M 10-Q · filed 2015-12-08 | |||||
| 2014-04-25 | $10.66M 10-K · filed 2017-03-01 | |||||
| 2013-04-26 | $10.19M 10-KT · filed 2016-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |